Kent International Holdings, Inc. does not have significant operations. It intends to pursue business opportunities in China, eastern Europe, and the United States. Previously, Kent International Holdings was engaged in the discovery and development of novel therapeutics for the treatment of inflammatory disorders, principally protease inhibitors, and bradykinin antagonists. The company was incorporated in 1982. It was formerly known as Cortech, Inc. and changed its name to Kent International Holdings, Inc. in May 2006. The company is based in Bedminster, New Jersey.